Inhibition of osteoclast formation and function by bicarbonate: Role of soluble adenylyl cyclase

Journal of Cellular Physiology

Volumn 220, Issue 2, 2009, Pages 332-340

  Geng, Weidong ^a,b   Hill, Kathy ^a   Zerwekh, Joseph E ^a,b   Kohler, Thomas ^c   Müller, Ralph ^c   Moe, Orson W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 8 BROMO CYCLIC AMP; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADENOSINE TRIPHOSPHATASE; ADENYLATE CYCLASE; BICARBONATE; OSTEOCLAST DIFFERENTIATION FACTOR; SMALL INTERFERING RNA; 2-HYDROXYESTRADIOL; ACID PHOSPHATASE; DRUG DERIVATIVE; ESTRADIOL; ISOENZYME; PROTON; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CALVARIA; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; SKULL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ACID PHOSPHATASE; ADENYLATE CYCLASE; ANIMALS; BICARBONATES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; ESTRADIOL; FEMALE; HUMANS; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; PROTONS; RNA, SMALL INTERFERING; SKULL; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 67649321812     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21767     Document Type: Article

References (41)

1. Arnett TR, Dempster DW. 1990. Protons and osteoclasts. J Bone Miner Res 5:1099-1103.
2. Battaglino R, VokesM, Schulze-Spate U, SharmaA, Graves D, Kohler T, Muller R, Yoganathan S, Stashenko P. 2007. Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem 100:1387-1394.
3. Beranger GE, Momier D, Rochet N, Quincey D, Guigonis JM, Samson M, Carle GF, Scimeca JC. 2006. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis. J Bone Miner Res 21:1757-1769.
4. Buck J, Sinclair ML, Schapal L, Cann MJ, Levin LR. 1999. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc Natl Acad Sci USA 96:79-84.
5. Buclin T, Cosma M, Appenzeller M, Jacquet AF, Decosterd LA, Biollaz J, Burckhardt P. 2001. Diet acids and alkalis influence calcium retention in bone. Osteoporos Int 12:493-499.
6. Bushinsky DA. 1995. Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis. Am J Physiol 268:C80-C88.
7. Bushinsky DA. 1996. Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts. Am J Physiol 271:F216-F222.
8. Bushinsky DA. 2001. Acid-base imbalance and the skeleton. Eur J Nutr 40:238-244.
9. Chen Y,CannMJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR, Buck J. 2000. Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 289:625-628.
10. Esposito G, Jaiswal BS, Xie F, Krajnc-Franken MA, Robben TJ, Strik AM, Kuil C, Philipsen RL, van Duin M, Conti M, Gossen JA. 2004. Mice deficient for soluble adenylyl cyclase are infertile because of a severe sperm-motility defect. Proc Natl Acad Sci USA 101:2993-2998.
11. Geng W,Wang Z, Zhang J, Reed BY, Pak CY, MoeOW.2005. Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol 288:C1305-C1316.
12. Goldhaber P, Rabadjija L. 1987. H+ stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol 253:E90-E98.
13. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. 1999. Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174.
14. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y,Nakamichi Y, MetzgerD, Chambon P, Nakamura K, Kawaguchi H, Kato S. 2003. Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100:9416-9421.
15. Khosla S. 2001. Minireview: The OPG/RANKL/RANK system. Endocrinology 142:5050-5055.
16. Kraut JA, Mishler DR, Singer FR, Goodman WG. 1986. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int 30:694-700.
17. Krieger NS, Sessler NE, Bushinsky DA. 1992. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262:F442-F448.
18. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, SenaldiG, Guo J, Delaney J, BoyleWJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
19. Lee FY, Kim DW, Karmin JA, Hong D, Chang SS, FujisawaM, Takayanagi H, Bigliani LU, Blaine TA, Lee HJ. 2005. mu-Calpain regulates receptor activator ofNF-kappaB ligand (RANKL)-supported osteoclastogenesis via NF-kappaB activation in RAW 264.7 cells. J Biol Chem 280:29929-29936.
20. Manolson MF, Yu H, ChenW, Yao Y, Li K, Lees RL, Heersche JN. 2003. The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large >or=10 nuclei) and small (
21. New SA. 1999. Bone health: The role of micronutrients. Br Med Bull 55:619-633.
22. New SA, Robins SP, Campbell MK, Martin JC, GartonMJ, Bolton-Smith C, Grubb DA, Lee SJ, Reid DM. 2000. Dietary influences on bone mass and bone metabolism: Further evidence of a positive link between fruit and vegetable consumption and bone health?AmJClin Nutr 71:142-151.
23. Osdoby P, Martini MC, Caplan AI. 1982. Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J Exp Zool 224:331-344.
24. Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg P. 1993. Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: Evidence of disturbed calcium, bone and citrate metabolism. Urol Res 21:169-173.
25. Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD. 2003. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 169:465-469.
26. Pastor-Soler N, Beaulieu V, Litvin TN, Da Silva N, Chen Y, Brown D, Buck J, Levin LR, Breton S. 2003. Bicarbonate-regulated adenylyl cyclase (sAC) is a sensor that regulates pHdependent V-ATPase recycling. J Biol Chem 278:49523-49529.
27. Preminger GM, Harvey JA, Pak CY. 1985. Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity. J Urol 134:658-661.
28. Reed BY, Heller HJ, Gitomer WL, Pak CY. 1999. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 84:3907-3913.
29. Rhee EJ, Oh KW, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Kang JH, Lee MH, Kim SW, Park JR. 2006. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease. Metabolism 55: 1344-1351.
30. Roodman GD. 1999. Cell biology of the osteoclast. Exp Hematol 27:1229-1241.
31. Rousselle AV, Heymann D. 2002. Osteoclastic acidification pathways during bone resorption. Bone 30:533-540.
32. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
33. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840.
34. Takahashi N, UdagawaN, Suda T. 1999.Anew member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 256:449-455.
35. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. 1999. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69:727-736.
36. Wan Y, Chong LW, Evans RM. 2007. PPAR-gamma regulates osteoclastogenesis in mice.Nat Med 13:1496-1503.
37. Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D, Redini F. 2004. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Exp Cell Res 293:292-301.
38. Yang JH, Amoui M, Lau KH. 2007. Targeted deletion of the osteoclast protein-tyrosine phosphatase (PTP-oc) promoter prevents RANKL-mediated osteoclastic differentiation of RAW264.7 cells. FEBS Lett 581:2503-2508.
39. Yasuda H, ShimaN,NakagawaN, Yamaguchi K, KinosakiM, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, TakahashiN, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
40. Zerwekh JE, Reed-Gitomer BY, Pak CY. 2002. Pathogenesis of hypercalciuric nephrolithiasis. Endocrinol Metab Clin North Am 31:869-884.
41. Zippin JH, Chen Y, Nahirney P, Kamenetsky M, Wuttke MS, Fischman DA, Levin LR, Buck J. 2003. Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J 17:82-84.